DRKS00009021
Recruiting
未知
Focal therapy of prostate cancer using mpMRI/TRUS-guided high intensity focused ultrasound (HIFU) technology: a prospective register study (FOXPRO_REGISTER) - FOXPRO_REGISTER
Klinik für Urologie, Universitätsmedizin Mannheim0 sites50 target enrollmentOctober 19, 2015
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- C61
- Sponsor
- Klinik für Urologie, Universitätsmedizin Mannheim
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •refusion of guideline conform prostate cancer therapy
- •\- serum PSA: PSA \= 30 ng/ml
- •\- mpMRT/TRUS bioptic proven prostate cancer:
- •Clinical stage: localized
- •\- No inclusion into trial FOXPRO or FOXPRO\_RAD possible
Exclusion Criteria
- •acute urinary tract infection; lymph node or bone metastasis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Focal therapy of localized prostate cancer using mpMRI/TRUS-guided high intensity focused ultrasound (HIFU) technologyC61Malignant neoplasm of prostateDRKS00007105Klinik für Urologie, Universitätsmedizin Mannheim50
Completed
Phase 2
MR Image Guided Therapy in Prostate CancerProstate CancerProstatic NeoplasmsNCT01377753National Cancer Institute (NCI)15
Recruiting
Not Applicable
MRI/TRUS fusion target biopsy against prostate cancer using real-time virtual sonographyJPRN-UMIN000026710agoya City University Graduate School of Medical Sciences275
Recruiting
Phase 2
Primary focal therapy for prostate cancer using low-dose-rate brachytherapyprostate cancerJPRN-UMIN000050997Saitama Cancer Center200
Completed
Not Applicable
Detecting local recurrent prostate cancer: MRI:patterns of post-prostatectomy recurrence and of its response to salvege radiotherapy using Enhanced and Dynamic Contrast Enhanced (DCE) MRIC61Malignant neoplasm of prostateDRKS00003469niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde33